An 11-year-old boy had two rare pouches flanking his bladder base. A single functional test explained why he avoided an operation entirely.

CPSC announced recalls of Hustler and BigDog mower LED light kits over fire risk and Studio Six amplifiers over electrocution risk.

Eplontersen missed its primary endpoint in a 1,432-patient heart amyloidosis trial. Widespread use of another drug may explain the neutral result.

New ESC heart failure guidelines drop one category, redefine ejection fraction cutoffs, and name core drug classes. What patients should know.

ASU hockey player Matthew Mayich remains in a coma after an outdoor workout. What heat illness looks like and when to act.

Two phase 3 trials found quarterly plozasiran injections cut triglycerides by about 80 percent and reduced acute pancreatitis events by 78 percent.

A new report documents 592 silicosis cases among California engineered stone workers, including 31 deaths and 65 lung transplants since 2019.

CDC guidance warns that antibody testing can miss arboviral infection in patients on B cell drugs, as West Nile season enters its peak weeks.

A seven year trial in 326 rural Chinese villages found intensive blood pressure control lowered dementia risk by 15 percent versus usual care.

A sham controlled trial found ablation cut atrial fibrillation recurrence but did not improve quality of life more than a placebo procedure.